2022 Biopharma Trends: US-Based Suppliers, Digitization, and Sustainability

In this episode of the Drug Solutions podcast, Chris Spivey, editorial director, and Meg Rivers, senior editor, interview experts on up-and-coming 2022 trends in the bio/pharma industry. The experts who shared their insight include: Peter Walters, Director of ATMP, CRB Yvonne Duckworth, Automation Engineer, CRB Cary Martin, VP of Marketing, August Bioservices Gabe Longoria, Chief Commercial Officer, Astrea Bioseparations Merrilee Whitney, Head of Biocontinuum Platform, MilliporeSigma Helen Anderson, Commercial Lead, USA, Aspen San Kiang, CTO, Porton Pharmatech/J-Star Research Anil Kane, Global Head of Technical Scientific Affairs, Pharma Services, Thermo Fisher Scientific Matthias Buserius, Head of Activities and Formulation, MilliporeSigma Jeff Woodhead, Senior Scientist, Simulations Plus Gregory Lane, PhD, Senior Research Investigator, Bristol-Myers, Squibb

There are no comments yet.

Please log in to write the first comment.